• Explore /
  • Poster
  • / Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: Final analysis of a randomized phase II trial (BINGO).

Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: Final analysis of a randomized phase II trial (BINGO).

Abstract Poster

Authors

null

David Malka

Institut Gustave Roussy, Villejuif, France

David Malka , Laetitia Fartoux , Vanessa Rousseau , Tanja Trarbach , Eveline Boucher , Christelle De La Fouchardiere , Sandrine J. Faivre , Frédéric Viret , Jean-Frédéric Blanc , Eric Assenat , Pascal Hammel , Christophe Louvet , Goetz von Wichert , Michel Ducreux , Olivier Rosmorduc , Jean-Pierre Pignon , Tim F Greten

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT00552149

Citation

J Clin Oncol 30, 2012 (suppl; abstr 4032)

DOI

10.1200/jco.2012.30.15_suppl.4032

Abstract #

4032

Poster Bd #

24

Abstract Disclosures

Similar Posters

First Author: Francesco Leone

First Author: Choong-kun Lee

First Author: Lars Henrik Jensen

Poster

2014 Gastrointestinal Cancers Symposium

A single-arm phase II trial of gemcitabine, oxaliplatin, and panitumumab in KRAS wild-type advanced biliary tract cancer.

A single-arm phase II trial of gemcitabine, oxaliplatin, and panitumumab in KRAS wild-type advanced biliary tract cancer.

First Author: Marcus Smith Noel